MHCD:CA:TSX-Middlefield Healthcare Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 11.44

Change

+0.01 (+0.09)%

Market Cap

CAD 0.16B

Volume

2.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.02 (+0.04%)

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

-0.28 (-1.56%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.94 (+1.48%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+0.53 (+1.31%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

+0.29 (+0.98%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

-0.12 (-1.33%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

N/A

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.14 (+0.65%)

CAD 2.78B

ETFs Containing MHCD:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.72% 73% C 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.72% 73% C 63% D
Trailing 12 Months  
Capital Gain 0.44% 33% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.44% 29% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.02% 47% F 42% F
Dividend Return 0.04% 46% F 34% F
Total Return 0.02% 27% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 3.51% 85% B 94% A
Risk Adjusted Return 1.04% 46% F 34% F
Market Capitalization 0.16B 74% C 45% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.